News – Page 504 – Endpoints News

Manufacturing roundup: WuXi continues its expansion drive with another plant opening in Changzhou; Swiss biotech nets ...

3 years ago

Senators again point to AbbVie as a poster child for reform. Only this time Dems are targeting a low, low tax rate

3 years ago

Adverum lays off 38% of staff as it enters new trial for ocular gene therapy after last year's safety woes

3 years ago

Pushing mRNA therapeutics for cancer, Cambridge startup nabs Series A to explore next-gen approach

3 years ago

European manufacturer Fagron expands its US presence by acquiring a facility on the East Coast

3 years ago

Legend scraps trial of its follow-up autologous CAR-T weeks after clinical hold was lifted

3 years ago

Two years after CRL, Intercept will meet with FDA later this month to discuss new analysis of NASH drug

3 years ago

As ALS patients unite around Amylyx, a new paper hints at potential druggable targets

3 years ago

Low-profile biotech led by Bristol Myers vets grabs a suite of adenosine receptor antagonists via tiny buyout

3 years ago

Scuttled by a bad IV bag? A small biotech is slapped with a hold following three SAEs

3 years ago

Fresh report of 'advanced' $40B+ Seagen buyout talks spurs more buzz about FTC showdown

3 years ago

CytomX halts lead program and will seek a partner as breast cancer drug disappoints

3 years ago

‘Unconscious biases’ and lack of trust lead to gaps in routine healthcare for LGBTQ+ community — study

3 years ago

Lotte Group turns to Merck KGaA’s US unit for leg up at new Syracuse biologics plant

3 years ago

Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports

3 years ago

Mylan Pharmaceuticals faces another recall on insulin injection pens

3 years ago

GSK's consumer health spinoff Haleon preps launch with $12B+ in debt

3 years ago

As new monkeypox cases spike globally, Labcorp rolls out first national lab test

3 years ago

Pulmonologist and frequent NBC guest in consideration for senior role at FDA — report

3 years ago

In wake of IP claims targeting its megablockbuster, BioNTech mulls a few next steps of its own

3 years ago

Heart inflammation emerges in a Sarepta Duchenne patient, clouding an otherwise positive readout

3 years ago

Two months after CRL, FDA accepts Coherus, Junshi's resubmission for PD-1 studied in China

3 years ago

Applied Molecular Transport’s shot at beating Humira in UC fails in mid-stage study, sinking shares nearly 30%

3 years ago

Catalent’s new CEO takes the reins as the drug manufacturer adjusts its operational structure

3 years ago

First page Previous page 501 502 503504505 506 507 Next page Last page